Guardant Health (MEX:GH) Pre-Tax Income : MXN-9,085 Mil (TTM As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Guardant Health Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Guardant Health's pretax income for the three months ended in Sep. 2024 was MXN-2,121 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2024 was MXN-9,085 Mil. Guardant Health's pretax margin was -56.26%.

During the past 8 years, Guardant Health's highest Pretax Margin was -32.52%. The lowest was -182.71%. And the median was -97.91%.

Guardant Health Pre-Tax Income Historical Data

The historical data trend for Guardant Health's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guardant Health Pre-Tax Income Chart

Guardant Health Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

-1,314.98

-4,891.52

-7,887.02

-12,739.64

-8,126.66

Guardant Health Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Pre-Tax Income	Get a 7-Day Free Trial															-1,491.27	-3,184.10	-1,901.60	-1,877.72	-2,121.12

Competitive Comparison of Guardant Health's Pre-Tax Income

For the Diagnostics & Research subindustry, Guardant Health's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guardant Health's Pre-Tax Income Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Guardant Health's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Guardant Health's Pre-Tax Income falls into.

Guardant Health Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Guardant Health's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-9585.782	+	902.589	+	-43.76	+	600.294	+	0
	=	-8,127

Guardant Health's Pretax Income for the quarter that ended in Sep. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-2310.224	+	-59.209	+	-12.72	+	261.034	+	0.00099999999974898
	=	-2,121

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-9,085 Mil.

Guardant Health (MEX:GH) Pre-Tax Income Explanation

Guardant Health's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-2121.118	/	3770.22
	=	-56.26%

During the past 8 years, Guardant Health's highest Pretax Margin was -32.52%. The lowest was -182.71%. And the median was -97.91%.

Guardant Health Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Guardant Health's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Guardant Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Guardant Health Inc (MEX:GH) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

GH:USA 5GH:Germany

Address

3100 Hanover Street, Palo Alto, CA, USA, 94304

Website

https://www.guardanthealth.com

Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.